메뉴 건너뛰기




Volumn 97, Issue 6, 2002, Pages 1285-1288

Liver biopsy: Who should do it ... and who will show up in court?

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; RIBAVIRIN;

EID: 0036089319     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(02)04120-5     Document Type: Editorial
Times cited : (9)

References (22)
  • 5
    • 0032865830 scopus 로고    scopus 로고
    • Guidelines on the use of liver biopsy in clinical practice
    • (1999) Gut , vol.45 , Issue.SUPPL. IV , pp. 1-11
    • Grant, A.1    Neuberger, J.2
  • 8
    • 0033849619 scopus 로고    scopus 로고
    • Practices of liver biopsy in France: Results of a prospective nationwide survey
    • For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF)
    • (2000) Hepatology , vol.32 , pp. 477-481
    • Cadranel, J.F.1    Rufat, P.2    Degos, F.3
  • 15
    • 0032585237 scopus 로고    scopus 로고
    • Randomised trial of interferon a 2b plus ribavirin for 48 weeks or for 24 weeks versus interferon a 2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
    • International Hepatitis Interventional Therapy Group
    • (1998) Lancet , vol.352 , pp. 1426-1432
    • Poynard, T.1    Marcellin, P.2    Lee, S.S.3
  • 19
    • 85046524402 scopus 로고    scopus 로고
    • Clinical utility of early viral load quantification
    • letter
    • (2000) Hepatology , vol.32 , pp. 158
    • Colluci, G.C.1
  • 21
    • 0034619548 scopus 로고    scopus 로고
    • Watchful waiting with periodic liver biopsy versus immediate empirical therapy for histologically mild chronic hepatitis C
    • (2000) Ann Intern Med , vol.133 , pp. 665-675
    • Wong, J.B.1    Koff, R.S.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.